Evidence map›Paper›PMID 26306214›Full record

ArticleWestern Pacific surveillance and response journal : WPSAR

Hepatitis A outbreak in Ba subdivision, Fiji, October-December 2013.

Aneley Getahun, Eric Rafai, Maria Ximena Tolosa, Akanisi Dawainavesi, Anaseini Maisema Tabua, Josefa Tabua

Abstract read
In one paragraph

Article in Western Pacific surveillance and response journal : WPSAR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aneley GetahunSchool of Public Health and Primary Care, College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji .
Eric RafaiFiji Ministry of Health, Suva, Fiji .
Maria Ximena TolosaAustralian Volunteer for International Development, Suva, Fiji .
Akanisi DawainavesiFiji Centre Communicable Diseases Control, Ministry of Health, Suva, Fiji .
Anaseini Maisema TabuaBa Medical Subdivision, Western Health Services, Suva, Fiji .
Josefa TabuaBa Medical Subdivision, Western Health Services, Suva, Fiji .

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA cluster of suspected hepatitis A cases was notified to the Fiji Ministry of Health on 22 October 2013. An outbreak investigation team was mobilized to confirm the existence of an outbreak of hepatitis A and advise appropriate public health interventions.

methodsA case definition for the outbreak investigation was established, and standardized data collection tools were used to collect information on clinical presentation and risk factors. An environmental assessment was also conducted.

resultsThere were 160 clinical cases of hepatitis A of which 15 were laboratory-confirmed. The attack rate was 349 per 10,000 population in the Nukuloa nursing zone; there were no reported deaths. Residents of the Nukuloa settlement were 6.6 times more likely to present with symptomatic hepatitis A infection (95% confidence interval: 3.8-12.6) compared with residents of another village with a different water supply. DISCUSSION: This is the first significant hepatitis A outbreak documented in Ba subdivision and possibly in Fiji. Enhanced surveillance of hepatitis A may reveal other clusters in the country. Improving the primary water source dramatically reduced the occurance of disease in the affected community and adjacent areas.

Indexed as

Disease OutbreaksAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleFijiHepatitis AHumansIncidenceMaleMiddle AgedRisk FactorsWater Supply

Identifiers

PMID26306214
PMCPMC4542484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.